Patients With Microscopic Colitis Are at Higher Risk of Major Adverse Cardiovascular Events: A Matched Cohort Study

Anders Forss1, David Bergman2, Bjorn Roelstraete2

  • 1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Gastroenterology Unit, Department of Gastroenterology, Dermatovenereology and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.

Abstract

Insights

Microscopic colitis (MC) patients face a significantly higher risk of major adverse cardiovascular events (MACE), including heart disease and stroke. This finding highlights the importance of cardiovascular monitoring in individuals with microscopic colitis.

Area of Science:

  • Gastroenterology and Cardiology
  • Inflammatory Bowel Disease Research
  • Public Health and Epidemiology

Background:

  • Inflammatory diseases are linked to increased cardiovascular risk.
  • Large-scale data on major adverse cardiovascular events (MACE) in microscopic colitis (MC) cohorts are limited.

Purpose of the Study:

  • To investigate the association between microscopic colitis and the risk of incident major adverse cardiovascular events (MACE).
  • To quantify the cardiovascular risk in a large, population-based cohort of Swedish adults diagnosed with MC.

Main Methods:

  • A nationwide cohort study of 11,018 Swedish adults with MC (1990-2017), matched with 48,371 reference individuals.
  • MC diagnosis confirmed via histopathology; MACE included ischemic heart disease, congestive heart failure, stroke, and cardiovascular mortality.
  • Cox proportional hazards modeling used to calculate multivariable-adjusted hazard ratios, with sensitivity analyses including sibling comparisons.

Main Results:

  • MC patients exhibited a 27% higher overall risk of MACE (aHR, 1.27; 95% CI, 1.21-1.33) compared to controls.
  • Increased risks were observed for ischemic heart disease (aHR, 1.38), congestive heart failure (aHR, 1.32), and stroke (aHR, 1.12).
  • No significant increase in cardiovascular mortality risk was found (aHR, 1.07).

Conclusions:

  • Microscopic colitis is associated with a significantly elevated risk of incident major adverse cardiovascular events.
  • The findings suggest a need for increased cardiovascular surveillance in patients diagnosed with microscopic colitis.
  • One additional MACE case occurs for every 13 MC patients followed for 10 years.

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
227
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
57
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
493
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
365
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
306
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
596